Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Erratum: Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 31, 2026
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 21, 2024
Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report.
Journal: Neuro-oncology
Published: August 04, 2021
COVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas.
Journal: Pediatric hematology and oncology
Published: May 25, 2021
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 28, 2020
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212).
Journal: Cancer chemotherapy and pharmacology
Published: June 12, 2020
A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study.
Journal: Neuro-oncology
Published: February 04, 2020
A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma.
Journal: Pediatric blood & cancer
Published: January 30, 2020
Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411).
Journal: Pediatric blood & cancer
Published: September 11, 2019
Editorial: Recent advances in pediatric oncology.
Journal: Current opinion in pediatrics
Published: January 08, 2019
A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 26, 2018
Last Updated: 09/26/2026